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Abstract
Background: The prevalence of type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD) is rising globally.
T2DM is particularly problematic in South Asia with an estimated 10–15% of Sri Lankans diagnosed with the
disease. Exercise is known to improve blood glucose, lipid profiles, blood pressure and adiposity, key goals in the
management of T2DM. However, much of the evidence to date has been gained from white Caucasians who have
a different body composition and disease profile compared to South Asians. Similarly, the recreational exercise
culture is new to Sri Lankans and the effects of exercise on T2DM has not been studied in this population.
Methods: The Sri Lanka Diabetes Aerobic and Resistance Training (SL-DART) Study will be comprised of 2
components. Component 1 is a 12-week randomized controlled trial (RCT) to compare the effects of a supervised
progressive resistance exercise program (RT) and aerobic exercise program (AT) with standard treatment/control
(CN). Sedentary Sri Lankan adults with T2DM (aged 35–65 years) and with no contraindications to exercise will be
randomized into one of 3 groups (AT, RT, CN). Exercise sessions will be conducted 2 days/week for 3 months.
Baseline and post-intervention biochemical (glycemic control, lipid and liver profiles, inflammatory markers),
anthropometric (height, weight, body circumferences), body composition, physical fitness, food preference (liking
and wanting food) and quality of life parameters will be measured and compared between groups. Component 2
will be a qualitative study conducted immediately post-intervention via in-depth interviews to assess the barriers
and facilitators for adherence to each exercise program.
Discussion: SL-DART Study represents one of the first adequately powered methodologically sound RCTs
conducted in South Asia to assess the effects of resistance and aerobic exercise in participants with T2DM.
Triangulation of quantitative and qualitative outcomes will enable the design of a culturally appropriate therapeutic
physical activity intervention for Sri Lankans with T2DM, and the initiation of a professionally driven and specialized
clinical exercise prescription service.
Trial registration: Sri Lanka Clinical Trials Registry; SLCTR/2016/017. Date registered 17.06.2016. Universal trial
number U1111–1181-7561.
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Background
Type 2 diabetes mellitus (T2DM) and cardiovascular
diseases (CVD) are major contributors to rising global
mortality [1–3]. South Asia is home to almost one-fifth
of the world’s population [4], a sub-population more
prone to T2DM compared to other ethnicities [5]. In
addition, an estimated 25 million people of South Asian
origin (India, Pakistan, Bangladesh, Nepal, and Sri Lanka)
[4] are living outside the region and similar prevalence
rates have been reported in migrants in the USA, Canada,
and various European countries [5]. There is a high preva-
lence of T2DM (10–15%) in South Asian Sri Lankans [6]
who are at a greater risk of CVD [7] and develop T2DM
at a younger age with increased incidence of complica-
tions (retinopathy, nephropathy, and coronary artery and
cerebrovascular disease) than white Caucasians [5].
A number of explanations have been proposed to
explain these ethnic differences, most commonly differ-
ences in body composition. For example, compared to
white Caucasians, South Asians have increased abdominal
adiposity/central obesity leading to insulin resistance (IR),
T2DM and CVD [5]. This phenomenon can be explained
in ‘adipose tissue compartment overflow hypothesis’ [8],
stating the superficial subcutaneous tissue is less devel-
oped in South Asians, resulting in early expansion of the
visceral and deep subcutaneous compartments [5, 9]. In
addition the ‘thrifty genotype hypothesis’ states some
people (possibly South Asians) can possess genes facilitat-
ing increased fat storage during food abundance for
survival during later famine [10].
Sri Lanka is also experiencing a socio-economic or
nutrition transition, a change from a more active
agricultural lifestyle to a more sedentary lifestyle due to
industrialization and urbanization and resultant overweight
and obesity [6]. Historically, structured recreational exer-
cise has not been a part of the culture in Sri Lanka [11]
and it is uncommon to see recreational exercise groups,
gymnasia and professionally trained staff. Poor food
choices are also contributing to less than desirable health
outcomes. For example, only 3–5% of Sri Lankan adults
consume the recommended 5 portions of fruits and vege-
tables per day and diets are characterized by higher por-
tions of rice and less protein (mainly by rice and pulses),
almost half that of US adults [12]. Prevention and manage-
ment of an estimated 1–1.5 million people with pre-
diabetes and diabetes is causing an escalating burden to
the Sri Lankan economy and society. There is a need to
develop effective management strategies to prevent a
worsening of the problem.
Exercise is known to improve blood glucose, lipid
profiles, blood pressure [13] and visceral adiposity [14],
key goals of diabetes management, with food intake and
quality of life also considered as important factors.
Combined aerobic exercise training (AT) and resistance
exercise training (RT) interventions have been widely
utilized in white Caucasians populations [15]with bene-
fits also reported for either exercise modality when used
individually [16, 17]. It has been suggested that South
Asians could benefit more from RT due to their
relatively higher adiposity and lower lean body mass
compared to Caucasians [18]. Currently, no Sri Lankan
studies have documented and very few South Asian
studies have compared the effects of AT plus RT on
people with T2DM. Secondly, low compliance and ad-
herence is a common drawback in exercise interventions
with information on the qualitative factors associated
with non-adherence to exercise often overlooked [19].
Finally, relatively few South Asian studies have addressed
food intake and the effects of AT and RT on food prefer-
ence [20].
Aims of the study
The primary aim of the Sri Lanka Diabetes Aerobic and
Resistance Training (SL-DART) Study is to investigate
the effect of two exercise modalities in Sri Lankan adults
(aged 35–65 years) diagnosed with T2DM. A 12-week
randomized controlled trial (RCT) will compare AT, RT
and usual care on the primary outcome measure, gly-
cemic control (HbA1c). Secondary outcome measures
include percentage body fat, blood lipid and liver
profiles, inflammatory markers, muscle strength, car-
diovascular endurance, blood pressure, quality of life
attributes and food preferences. A secondary aim is
the qualitative assessment of barriers/facilitators to com-
pliance and adherence to different modes of exercise via
in-depth interviews.
To the best of our knowledge, a study of this nature
has not been conducted in Sri Lanka or in other parts of
South Asia. In a culturally diverse setting like Sri Lanka,
the development of a feasible exercise intervention for
T2DM would therefore be very novel. The experiences
of SL-DART Study will enable the development of a
culturally acceptable clinical exercise physiology service
to people with T2DM.
Methods
Study design
 Pilot study
 Component 1: A 12-week RCT will study the effects
of a supervised RT and AT program on behavioral,
anthropometric, physical fitness, appetite and
biochemical parameters in sedentary Sri Lankan
adults with T2DM (aged 35–65 years) with no
contraindications to exercise. Outcomes will be
compared between exercise programs and a
control group who receive standard care.
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 Component 2: A qualitative study will be
undertaken immediately after the intervention to
assess the barriers and facilitators for adherence to
each program (refer to Figs. 1 and 2).
Settings and study population
The study will be conducted in the Faculty of Medicine,
University of Colombo, Sri Lanka with training carried
out at the University’s Strength Training Gymnasium.
The study population will be recruited from patients
attending the medical and diabetic clinics of the
National Hospital Sri Lanka (NHSL) and private sector
endocrine clinics in Colombo after prior approval from
the consultant physician in-charge.
Preliminary study/pilot study
A 4-week pilot study was conducted to pretest the main
study design methodology. Nine (N = 9) participants
were recruited into each group (n = 3, Male: Female AT
1:2, RT 1:2, CN 2:1) and all completed the intervention.
Main outcome of the pilot study was the change in
HbA1c.The baseline values for HbA1c (Mean, SD) were
8.0(1.4)/7.7 (1.7)/8.3%(1.7) and post intervention values
were 7.8 (1.2)/ 7.4 (1.1)/ 8.2%(1.7) for AT, RT and CN re-
spectively. Challenges were identified in the difficulty of
recruitment, including excessive time taken. A trained
pre-intern medical doctor was recruited for initial
participant contact. Participant response and tolerance
to the intervention helped determine the duration of the
practice period (4 sessions) necessary to teach the
technical skills. The feasibility of the exercise protocol
was improved by confirming the frequency of participant
attendance (2 sessions/week), initial intensity and progres-
sion of exercises, testing the safety and first aid protocols
and specific time points for measuring intervention
outcomes. Technical and logistical constraints associated
with coordination between laboratories and institutions
were identified and improved. For example, access to the
gymnasium and the investigation laboratories was
improved by providing free car parking and transport
facilities when needed. The availability of the principal
investigator and exercise administrators at all times re-
sulted in increased retention of participants. Pre-testing of
all questionnaires was also undertaken.
Process evaluation
A number of strategies for documenting the imple-
mentation of the intervention were developed with the
pilot study. Standard Operating Procedures (SOPs) were
developed for participant recruitment, randomization,
screening, conducting pre- and post-intervention mea-
surements and implementation of the exercise interven-
tion. Dose of exercise to be delivered and its progression,
reach for the participants (logs of participant attendance,
participant experience about the intervention) were
included in the information booklet. The intervention
fidelity was separately assessed. Before the start of the
study, the methods by which they would be docu-
mented, who would be responsible for completing the
documentation, and procedures for data entry and
evaluation was decided and the investigators and ex-
ercise supervisors were trained accordingly.
Eligibility criteria
Inclusion criteria of participants include:
1. Non-cognitively impaired Sri Lankan males and
females (non-pregnant and not planning to fall
pregnant), aged 35–65 years, and diagnosed with
T2DM within the last 10 years.
2. Not participated in any exercise program within the
previous 6 months.
Participants will be excluded if blood HbA1c levels <
6.5% or > 11.5%, on insulin or thiazolidinedione therapy/
other than standard oral hypoglycemic agents, advanced
diabetes induced end-stage organ damage and history of
significant cardiovascular (ischemic heart disease etc.),
respiratory (asthma, chronic obstructive pulmonary
disease etc.), musculoskeletal diseases. To maintain
accuracy, the patient informant data will be cross-
checked with the patient health records in the clinic (e.g.
HbA1c levels, duration of diabetes, drug history etc.) by
the principal investigator who is an experienced medical
doctor.
Informed consent
Written informed consent will be obtained from all
participants prior to their entry into the study.
Fig. 1 Research plan
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Sample size
Ninety (n = 90) participants will be recruited from a roll-
in method and allocated to RT group (n = 30), AT group
(n = 30), or CN group (n = 30). The sample size was cal-
culated considering the expected change of glycosylated
hemoglobin (HbA1c) (primary outcome) of the partici-
pants. HbA1c is the main parameter to check long-term
glycemic control [14]. Previous studies have reported
that structured AT or RT had statistically and clinically
significant reduction of absolute HbA1c by about 0.6%
[21, 22]. Sample size was calculated to have 80% power
to detect a moderate 0.65-SD difference in HbA1c, with
an alpha/α value of 0.05. Additional participants will be
recruited until the required number is achieved (n = 38)
per group to account for the estimated drop-out rate of
15–25%.
Randomization and blinding
Adaptive covariate randomization will be carried out to
minimize allocation bias and balance important covari-
ates among treatment groups, which has been recom-
mended for clinical research with low sample sizes [23].
Staff who are responsible for exercise administering and
data collection will be blinded for the randomization
process. Blinding of exercise administers and partici-
pants to the intervention is not possible in exercise
intervention trials, whereas the outcome assessors
(trained staff in independent tertiary care laboratories)
Fig. 2 Flow chart of sampling, recruitment and progression of RCT/Study 1
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will be blinded [22]. Data analysis will be done by the
first author on a de-identified database.
Participant assessment and documentation
An information booklet will be used to record interviewer-
administered data collected from participants. Initially,
demographic data (name, age, gender, marital status, occu-
pation and income level), screening data for eligibility, and
background physical activity levels will be documented.
During the study, pre- and post-intervention behavioral, ap-
petite, anthropometry, physical fitness, biochemical param-
eters and the individual exercise protocols, plus details of
each exercise session (24–30 sessions), will be documented
by the exercise supervisors.
Screening
Screening will be undertaken via a thorough medical
history and physical activity readiness questionnaire
(PAR-Q) [24] followed by a physical examination con-
ducted by a qualified medical practitioner. The object-
ive is to exclude any condition mentioned in the
exclusion criteria and ensure safety for progressive ex-
ercise. Eligible participants will be allocated to one of
the groups and complete a 2D Echocardiogram and
Exercise/Stress electrocardiogram/ECG supervised by
a consultant cardiologist. Patients who fail the test
will be excluded from the study and referred for spe-
cialist care (see Fig. 2).
Intervention
The theoretical basis for the exercise intervention was
gleaned from current literature and guidelines from the
American College of Sports Medicine (ACSM) and
American Diabetes Association (ADA) [25, 26]. Eligible
participants will take part in an educational practice
period (4 sessions) at the University of Colombo
strength gymnasium 2 weeks prior to start of the inter-
vention proper. These sessions will assist participant
familiarization with the environment, teach them skills
techniques, assess tolerance to the frequency and inten-
sity of exercises etc. Participants will start with mini-
mum tolerable intensity, duration/repetitions and slowly
progress to the required exercise dose (AT: 60–70% of
HR max for 75 min, RT: 7 exercises all repetitions main-
taining 50% repetition maximum (RM) using correct
technique). Once participants achieve the minimum re-
quirement, as assessed by the principal investigator, they
will start the intervention proper. Pre-intervention (i.e.,
baseline) parameters will be measured one week before
starting the intervention proper (see Fig. 3).
RT-intervention group
Participants will follow a supervised progressive resistance
training program [26] with each session ~ 60–75 min in
duration, 2 times per week for 12 weeks. Duration of each
session will be tailored according to the capacity of each
individual and progressively accordingly. Exercise duration
per week will be approximately 150 min with each session
consisting of a warm-up, a resistance training component,
and a cool-down phase. There will be a 48-h rest period
between each session. With regard to frequency of
sessions, a recent review stated there is no significant
difference in benefits between 2/week of RT compared to
3/week of RT [27]. The 12-week exercise program will
allow adequate time for measurable changes in the group
(e.g. muscle fiber hypertrophy typically occurs 6–8 weeks
after initiating RT).
The RT phase will target biceps, triceps, pectoralis
group, core, quadriceps, hamstring, calf, trapezius, latissi-
mus dorsi and gluteal muscle groups with seven upper
body (shoulder press, lateral pull down and biceps curl),
lower body (leg press/squat, leg extension, heel lifts,) and
core (abdominal crunches starting with pelvic and core
muscle activation) exercises. Initial resistance for each ex-
ercise will be decided individually by testing strength via 1
repetition maximum/ 1RM [28] and determining max-
imum weight that can be lifted 8–10 times [17, 29]. The
volume of exercise will progress from 1 set of 8 repetitions
up to 3 sets (1 × 8 to 3 × 8) and then with increasing resist-
ance according to individual capacity and consistent with
the literature [27]. Body resistance, free weights and ma-
chines will be used in a circuit manner.
AT-intervention group
This group will follow a supervised progressive aerobic
training program with exercise intensity progressing up
to 60–75% of heart rate max (HRmax). Heart rate will be
measured using Polar heart rate monitors. During the
program, brisk walking on the treadmill, stepping up-
down, and stationary cycling will be used alternately.
Exercise intensity will be progressed according to individ-
ual tolerability, graded by HRmax and rating of perceived
exertion (RPE) using the Borg 6–20 scale. Initially, partici-
pants’ workload will be adjusted to achieve 60% of HRmax
and 8–9/20 RPE for 20–30 min and progressed to 75% of
HRmax [29] and 12–13/20 of RPE up to 75 min. Each
session will be 75 min in duration, 2 times per week
(150 min per week) continuously for 12 weeks with the
duration of each session tailored to the capacity of each
individual and progressively increased.
Control group-active control
This group will be provided with standard care - attend-
ing normal clinic visits to a consultant physician pre-
scribing medication and providing general health
education. No specific instructions will be provided
regarding exercise nor additional information regarding
dietary modifications. The group will complete all pre-
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and post-intervention measurements and participants
will be contacted via telephone once every 2 weeks
during the 12-week period.
Background physical activity Background physical
activity will be assessed in all participants using standard
pedometers (Yamax, Digi walker, CW- 600 Japan). Partici-
pants will wear a pedometer for 1 full week between
weeks 8 and 12 of the intervention, except when shower-
ing or sleeping. Background activity is the mean daily total
step count for the days the pedometer is worn, excluding
steps during scheduled exercise sessions. The Inter-
national Physical Activity Questionnaire (IPAQ) long ver-
sion [30] will also be used pre- and post-intervention to
assess the physical activity level of participants outside the
supervised exercise program. Participants will be advised
not to engage in any additional exercise outside the pre-
scribed program during the 3 months.
Safety Participants will be advised about hypoglycemic
symptoms during and after the exercise program and
about appropriate self-management procedures. Pre- and
post-exercise capillary blood glucose will be measured at
the initial period and as required to avoid hyper/
hypoglycemia during the intervention [31]. Participants
with a daily blood glucose level (BGL) exceeding 300 mg/
dL or 16.7 mmol/L [17, 26] will not engage in exercise
during that day and will be directed to appropriate
medical care. BGL less than 100 mg/dL or 5.5 mmol/L
[17, 26], will be provided with 15–30 g of glucose
and re-assessed by a qualified medical doctor on
BGL (< 100 mg/dL) and signs and symptoms of
hypoglycemia. They will be allowed to continue/
discontinue accordingly. An adequate amount of carbohy-
drate (glucose) and drinking water will be available to par-
ticipants during activity to avoid hypoglycemia and
dehydration. Blood pressure will be monitored before each
session. Emergency drugs and access to hospital will be
available in case of an emergency. Special precautions will
be taken to prevent injuries and blisters in patients’ feet
during the program.
Adherence to the intervention Continuous motivation
and advice on adherence to the program will be given
during sessions. Standard care in the management of
T2DM will be continued and no additional information
regarding dietary modifications will be provided. All
exercise programs will be prescribed and supervised by a
qualified medical doctor (principal investigator). Qualified
physiotherapists will be recruited as research assistants to
support one-on-one exercise sessions and administration
of the study (recruitment of participants, randomization,
and completion of questionnaires). Physical training in-
structors will be available in the gymnasium to provide
further support. The principal investigator and exercise
supervisors will be trained in clinical exercise prescription.
Intervention fidelity
Three exercise supervisors will deliver the exercise
protocol in a uniform. At random time points, an
independent assessor will observe classes and monitor
content consistency using a checklist on explicit areas
of the exercise protocol. The principal investigator
will check the exercise protocol log daily and the inde-
pendent assessor will review it at random intervals to
check that the intervention is delivered as intended.
Fig. 3 Specific data collection time points in the program
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Outcome measures
All outcomes are measured pre- (within one week before
the start date of the intervention) and post-intervention
(within one week after the intervention) (Table 1).
Primary outcome
Change in glycemic control
Primary outcome will be absolute change in glycosylated
hemoglobin (HbA1c) levels. HbA1c is the accepted par-
ameter to monitor long-term glycemic control (normal
values are 4–6.5%) [32]. Additionally, fasting blood sugar
levels (FBS) and fasting insulin (FI) levels will be
measured to further assess and compare change in insu-
lin resistance status. A venous blood sample will be
collected after an overnight fast by a trained medical
officer/investigator and transported to a standard tertiary
care laboratory for analysis. Laboratory technicians are
blinded to the study participants.
Secondary outcomes
Change in percentage body fat (%BF)
Total body fat percentage will be measured via dual energy
X-ray absorptiometry (DXA) full body scan [33], a gold
standard method for the assessment of body composition.
Additional details on regional body fat will be provided.
The DXA scan is completed in a standard tertiary care la-
boratory by a trained technician who is blinded to the study
participants. Body composition will also be assessed using
seven skin fold thickness measures (triceps, chest, sub
scapular, axillary, mid-thigh, abdominal and suprailiac skin
folds) [31] with a Harpenden skin fold caliper by the trained
principal investigator. All measurements will be taken in
the morning between 0900 and 1000 am by the same inves-
tigator to maintain consistency and inter-rater reliability.
The ISAK (International Society for the Advancement of
Kinanthropometry) methodology and American College of
Sports Medicine Guidelines will be used [34].
Skinfold thickness, body circumferences, and DXA will
enable a detailed appraisal of total and regional adipos-
ity. The addition of waist circumference and skinfold
thickness measures to DXA values will improve data on
central adiposity [33].
Lipid profile, liver profile and chronic inflammatory status
 Absolute change in plasma lipid profile, total
cholesterol (TC), triglycerides (TG), high-density
lipoproteins (HDLC), low-density lipoproteins
(LDLC) will indicate change in metabolic and
cardiovascular risk of participants [35].
 Change in highly sensitive serum C-reactive protein
(hs-CRP) will be measured to identify the chronic
inflammatory status, a predictor of future
cardiovascular risk [36].
 Serum Aspartate aminotransferase/Alanine
aminotransferase (AST/ALT) levels will be measured
to assess liver cell damage consistent with metabolic
derangement in metabolic syndrome and T2DM [37].
Anthropometry and cardiovascular/fitness parameters
 Anthropometry:
Table 1 Outcome variables and measuring instruments/procedures
Outcome variable Measuring instrument/procedure
Anthropometry: Height, weight, body circumferences
(waist, hip, mid-arm, mid-thigh)
∙ISAK guidelines.
∙Stadiometer, electronic weighing scale and measuring tape
(SECA, Germany)
Body fat % ∙Seven site skin fold measures by ISAK and ACSM guidelines.
∙Harpenden skin fold caliper.
Total and regional body composition ∙Dual energy X- ray absorptiometry (DXA) full body scan. Hologic
Discovery W, DXA system.
Cardiovascular endurance/Fitness ∙6 min walk test (6MWT).
∙Queens College/McArdle Step test.
∙Exercise Electrocardiogram (ECG).
Muscle strength ∙ACSM guidelines.
∙One repetition maximum (1RM) testing with machine and free
weights (Precor, USA).
Blood pressure OMRON digital blood pressure monitor (Japan).
Heart rate Polar heart rate monitors.
Biochemical parameters: Glycemic control (HbA1c FBS, Fasting insulin),
lipid level, liver enzymes, HsCRP.
Venous blood samples with overnight fast tested in tertiary care
independent laboratory.
Quality of life SF-36 quality-of-life outcomes questionnaire. Self-administered.
Liking and wanting for different types of food Computer-based behavioral procedure Leeds Food Preference
Questionnaire (LFPQ).Self-administered.
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Measurements will be taken in the morning between
0900 and 1000 am adhering to ISAK guidelines by the
trained principal investigator who is a qualified medical
practitioner. Height will be measured while the partici-
pant is barefoot to the nearest 0.1 cm using a portable
stadiometer (Seca 213, Germany). Weight will be mea-
sured (wearing light clothing without shoes) using an elec-
tronic weighing scale (Seca 813, Germany) and recorded
to the nearest 0.1 kg. Body Mass Index (BMI) will be cal-
culated using the standard calculation (weight/height 2
kgm− 2). Waist, hip, mid-arm, mid-thigh circumferences
will be measured using a non-elastic measuring tape (Seca
201, Germany) to the nearest 0.1 cm. A mean value will
be recorded after three consecutive measurements [31].
 Cardiovascular endurance and electrocardiographic
measures:
1. Exercise ECG will be undertaken at a tertiary care
hospital electrocardiographic laboratory under the
supervision of a consultant cardiologist and trained
staff using the Bruce protocol. Exercise ECG results
will provide profile electrocardiographic changes in
addition to blood pressure and heart rate changes to
progressive exercise.
2. YMCA 3-Minute Step Test will be used to
measure heart rate changes with acute progression
of exercise [31].
3. The 6-min walk test (6MWT) will be used to
measure endurance and the walkability of
participants [31].
 Resting and exercise heart rate will be monitored by
heart rate monitors (Polar). Systolic and diastolic
blood pressure will be measured using standard
methods by trained research assistants using an
Omron HEM-7130 electronic sphygmomanometer.
 Muscular strength: One Repetition Maximum
(1RM) will be assessed in all major muscle
groups [31].
Quality of life (QoL)
Change of Quality of Life will be assessed using the SF-
36 quality-of-life outcomes questionnaire [38] previously
validated in Sri Lanka.
Liking and wanting of food
Change in preference for a particular type of food (high
fat: sweet, high fat: savory, low fat: sweet, low fat savory)
will be assessed using the computer-based Leeds Food
Preference Questionnaire (LFPQ) [39]. This question-
naire will be customized to the Sri Lankan population by
adding Sri Lankan foods to different food categories
asked in the questions. The participant will initially be
trained to use the computer program by the investigator
before being self-administered.
Qualitative study
The primary outcome of the qualitative study is to
identify barriers and facilitators experienced during the
prescribed exercise programs using in-depth interviews
(IDIs). This will be carried out after the last exercise ses-
sion of the individual program by the principal investiga-
tor and a trained assistant. Face-to-face interviews will
be conducted with privacy maintained using a set of
pre-determined semi-structured open-ended questions
regarding; the stage of behavioral change, knowledge of
exercise, individual’s beliefs, perceived ability, limita-
tions/barriers and facilitators experienced during the
prescribed exercise programs.
During interviews, written notes will be taken and
responses from participants will be audio recorded, in-
cluding emotional responses. The number of interviews
will determined by data saturation which will be revealed
during concurrent analysis.
To the best of our knowledge, no studies have been
conducted to date where the effectiveness of a RCT has
been assessed via the qualitative experience of partici-
pants. This component will allow a triangulation approach
to incorporate quantitative and qualitative data at the
stage of results interpretation.
Data and statistical analysis
Quantitative data will be processed and analyzed using
SPSS version 20. To measure pre- and post-intervention
absolute changes in glycaemia, anthropometry, body
composition, metabolic and fitness parameters, liking/
wanting for food and quality of life across the groups; a
linear mixed model analysis for repeated measures that
includes the covariates age and sex will be used. The SF-
36 will be scored according to the guidelines provided
by the RAND Corporation [40] and additionally effect
size (Cohen’s d) will be assessed to determine change ef-
fect of each scale. The LFPQ will use Visual Analogue
Scale (VAS) scores for explicit liking/ wanting for food
and standardized ‘d-score’ (D-RT) for implicit wanting
for food using E-prime software. The effect p = 0.05 will
be considered statistically significant.
Qualitative data of the interviews will be audio recorded
and verbatim transcribed for analysis. The facilitator and
two observers will analyze their respective IDI using their
notes (verbal and non-verbal responses of participants)
and the tape-recorded data collectively immediately or
within 24 h after the conclusion of the IDI. Transcripts
will then be downloaded, coded, and analyzed for emer-
gent themes using NVivo 10 qualitative analysis software
[41]. The differences in coding will be resolved via discus-
sions by a group of independent reviewers.
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The data will be stored for future use after the com-
pletion of the study.
Discussion
Findings from the proposed study are expected to benefit
the knowledge base of health professionals in the South
Asian region and provide further evidence for the devel-
opment of specialised clinical exercise physiology services
in the country.
Despite the high prevalence of T2DM in Sri Lanka,
there are no published data on the effects of exercise in
patients with the condition. Further, no adequately
powered methodologically advanced trials have been
conducted in South Asia to quantify multiple parameters
regarding different modes of exercise prescription for
patients with diabetes.
Differences in the body composition and metabolic
profile of South Asians may differentially influence the
relative effects of aerobic and resistance exercises, com-
pared to other ethnicities. Further, the effects of exercise
on food preference has not been investigated among
South Asians and results will likely allow for better
planning of lifestyle interventions for Sri Lankans.
Globally, the management of chronic non-communicable
diseases (NCDs) is changing from a ‘disease’ to a
‘health’ model with a greater focus on lifestyle modifica-
tion. This study is planned in a society where recreational
‘exercise culture’ is not a norm and the development of
the new processes and services will be challenging. Find-
ings of the proposed study will inform the development of
a much needed professionally driven specialized service in
behavior change and lifestyle modification to combat the
NCD epidemic in the region.
The addition of a qualitative study to assess the
barriers and facilitators for adherence to the intervention
is also novel. Finally, we plan to triangulate quantitative
and qualitative outcomes and propose a culturally
adaptable therapeutic physical activity intervention to
Sri Lankan patients with T2DM and inform policy
makers.
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